Live Program Date: August 18, 2016 –
Master Program Number: 1612 (see program format numbers below under Registration)
Topic: Cellular Therapies
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching Level: Intermediate
Director/Moderator: Julie Allickson, PhD, Director, Regenerative Medicine Clinical Center, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
Speakers: Julie Allickson, PhD, Director, Regenerative Medicine Clinical Center, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC; Dimitris Karamichos, PhD, Assistant Professor, Department of Ophthalmology; Assistant Professor, Department of Cell Biology; Member/Faculty, Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Dennis O. Clegg, PhD, Professor, Wilcox Family Chair in BioMedicine, University of California Santa Barbara, Santa Barbara, CA
After participating in this educational activity, participants should be able to:
Provide an introduction to cell therapy in ocular engineering.
- Discuss clinical translation of ocular engineering in regenerative medicine.
- Discuss unmet clinical needs in corneal engineering and how therapies are applied.
Regenerative medicine has emerged as an innovative scientific field that focuses on the development of new approaches to repairing cells, tissues and organs for clinical applications. This program provided insights into the rapidly evolving field of ocular therapy in regenerative medicine. It also highlighted technologies that have been applied in patients as well as those that are currently in development.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||